Kanyos Bio
Homepage http://www.kanyos.com
LinkedIn Profile https://linkedin.com/company/ka***s-b***
HQ Location
United States , Massachusetts, CambridgeOne Kendall Square Building 1400W Cambridge, MA United States
Kanyos Bio was founded with the goal of developing antigen-specific immune tolerance technology for two specific autoimmune indications, type-1 diabetes and celiac disease.
Our technology originated at EPFL (Ecole Polytechnique Fédérale Lausanne) in Switzerland with our sister company, Anokion. Kanyos and Anokion are collaborating in this effort with Astellas Pharma, Inc. (“Astellas”). As an independent affiliate, Kanyos aims to develop antigen-specific, disease-modifying therapies for patients with type-1 diabetes and celiac disease by leveraging the immunotechnology expertise of Anokion and the clinical translation experience of Astellas.
Biotechnology and Molecular Biology Research
Companies in the biotechnology and molecular biology industry use advanced technologies to research and develop products that are used to diagnose or treat diseases. This also involves gene manipulation which can be used to create new medicines or vaccines.
Career Opportunities at Kanyos Bio
Stay updated on the latest job openings by checking back regularly or by visiting the company's official career page.
No job listings currently found.
Details of Kanyos Bio
Related Companies and Competitors
Access All Contact Details
Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive to ensure that the information is accurate and up-to-date, we cannot guarantee its completeness or accuracy. We do not endorse or guarantee the products or services of any company or individual listed.
